JANMARY BEAUCHAMP: Open Payments
NPI 1972871044 · DEBARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 34 payments from 15 companies in 2025. Trend: 2023 $913 · 2024 $1,122 · 2025 $829
Food & beverage: $696Education: $133
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $135 |
| GENZYME CORPORATION | 4 | $110 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $106 |
| Janssen Biotech, Inc. | 1 | $72 |
| LEO Pharma Inc. | 3 | $67 |
| Organon LLC | 3 | $62 |
| ABBVIE INC. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Incyte Corporation | 2 | $39 |
Products named: DUPIXENT, OTEZLA, TREMFYA, SKYRIZI, ADBRY, ILUMYA, Sotyktu, OPZELURA.
Industry payments across FL — which companies pay providers there.
